10:57 AM EDT, 03/22/2024 (MT Newswires) -- Lyra Therapeutics ( LYRA ) on Friday filed a registration statement for a $300 million mixed shelf offering of common stock, preferred stock, debt securities, warrants and units.

The filing also included a prospectus covering the offering of up to $75 million shares that may be sold from time to time under an agreement with Cantor Fitzgerald.

Price: 6.11, Change: +0.04, Percent Change: +0.66